SCN2A and epilepsy: SCN2A mutations that lead to a gain of Nav1.2 function are thought to induce early onset epilepsy, whereas those that lead to a loss of Nav1.2 function induce ASD and intellectual disability (Ben-Shalom et al., 2017; Wolff et al., 2017; Sanders et al., 2018).